Liver Tumors in Children von Litten, Jason B., Tomlinson, Gail E.

Volltext

Activated NOTCH2 is Overexpressed in Hepatoblastomas: An Immunohistochemical Study von Litten, Jason B., Chen, Tina T.-L., Schultz, Roger, Herman, Karl, Comstock, Jessica, Schiffman, Joshua, Tomlinson, Gail E., Rakheja, Dinesh

Volltext

Acute lymphoblastic leukemia presenting in fulminant hepatic failure von Litten, Jason B., Rodríguez, Maria M., Maniaci, Vincenzo

Volltext

Azacitidine, Venetoclax and Allogeneic NK Cells in Newly Diagnosed Acute Myeloid Leukemia (ADVENT-AML): An Investigator-Initiated Multicenter Phase Ib Trial von Maiti, Abhishek, Muftuoglu, Muharrem, Ignatz-Hoover, James J., DiNardo, Courtney D., Ravandi, Farhad, Andreeff, Michael, Xiao, Lianchun, Huang, Xuelin, Patel, Keyur P., Litten, Jason B, Bourk, Eliot, Astrow, Stephanie, Kantarjian, Hagop M., Tomlinson, Ben K., Daver, Naval, Wald, David

Volltext

TIGER 1: A randomized, open-label, phase 2/3 study of rociletinib (CO-1686) or erlotinib as first-line treatment for EGFR-mutant non-small cell lung cancer (NSCLC) von Camidge, D. Ross, Wolf, Juergen, Litten, Jason B., Higashi, Linda A, Isaacson, Jeffrey D., Mok, Tony

Volltext

Abstract OT1-1-13: A Phase 2, randomized, open-label, multicenter, safety and efficacy study of oral lucitanib in patients with metastatic breast cancer with alterations in the FGF... von Abu-Khalaf, Maysa, Mayer, Ingrid, Litten, Jason B, Raponi, Mitch, Allen, Andrew R, Pusztai, Lajos, Arteaga, Carlos L

Volltext

50 years ago in The Journal of Pediatrics von Litten, Jason B.

Volltext

A single arm, open-label, phase II study to assess the efficacy of lucitanib in patients with FGFR1 -amplified squamous NSCLC (sqNSCLC) von Spigel, David R., Cereda, Roberta, Litten, Jason B., Allen, Andrew R., Giaccone, Giuseppe, Socinski, Mark A., Camidge, D. Ross, Besse, Benjamin

Volltext

A phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors von Soria, Jean-Charles, De Braud, Filippo G., Bahleda, Ratislav, Adamo, Barbara, Cereda, Roberta, Camboni, Maria Gabriella, Robert, Renata, Isaacson, Jeffrey D., Litten, Jason B., Allen, Andrew R., Rolfe, Lindsey, Tabernero, Josep

Volltext

Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma (HCC) von Abou-Alfa, Ghassan K., Blanc, Jean-Frédéric, Miles, Steven, Ganten, Tom M., Trojan, Jorg, Cebon, Jonathan S., Liem, Andre K. D., Lipton, Lara Rachel, Gupta, Charu, Wu, Benjamin, Litten, Jason B., Saltz, Leonard

Volltext

Is preoperative chemotherapy useful for nonmetastatic Wilms' tumor? von Tomlinson, Gail E, Litten, Jason B

Volltext

CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME von LITTEN, Jason B, FLYNN, Peter, FARRELL, Thomas James, CHO, Sungyoo, LIM, John Kin Chuan, KIM, Yusun, HWANG, Yu Kyeong

Volltext bestellen

CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME von LITTEN, Jason B, FLYNN, Peter, FARRELL, Thomas James, CHO, Sungyoo, LIM, John Kin Chuan, KIM, Yusun, HWANG, Yu Kyeong

Volltext bestellen

TREATMENT OF CANCER WITH NK CELLS AND AN EGFR TARGETED ANTIBODY von LITTEN, Jason B, MANDAL, Mili, MIN, Bokyung, FLYNN, Peter, KIM, Eunji, FARRELL, Thomas James, CHO, Sungyoo, YANG, Bitna, LIM, John Kin Chuan, KIM, Yusun, HWANG, Yu Kyeong

Volltext bestellen

TREATMENT OF CANCER WITH NK CELLS AND MULTISPECIFIC ENGAGERS von LITTEN, Jason B, GRAEF, Thorsten, GUERRETTAZ, Lisa, KIM, Hyojin, SOMANCHI, Srinivas Sai, MIN, Bokyung, FLYNN, Peter, KOCH, Joachim, LEE, Sanghyun, FARRELL, Thomas James, RAYMON, Heather Karen, PAHL, Jens

Volltext bestellen

Treatment of cancer with nk cells and multispecific engagers von LEE Sanghyun, RAYMON Heather Karen, FARRELL Thomas James, GUERRETTAZ Lisa, KOCH Joachim, LITTEN Jason B, PAHL Jens, SOMANCHI Srinivas Sai, KIM Hyojin, GRAEF Thorsten, MIN Bokyung, FLYNN Peter

Volltext bestellen

TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY von LITTEN, Jason B, MANDAL, Mili, MIN, Bokyung, FLYNN, Peter, KIM, Eunji, FARRELL, Thomas James, CHO, Sungyoo, YANG, Bitna, LIM, John Kin Chuan, KIM, Yusun, HWANG, Yu Kyeong

Volltext bestellen

TREATMENT OF CANCER WITH NK CELLS AND MULTISPECIFIC ENGAGERS von LITTEN, Jason B, GRAEF, Thorsten, GUERRETTAZ, Lisa, KIM, Hyojin, SOMANCHI, Srinivas Sai, MIN, Bokyung, FLYNN, Peter, KOCH, Joachim, LEE, Sanghyun, FARRELL, Thomas James, RAYMON, Heather Karen, PAHL, Jens

Volltext bestellen

TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY von LITTEN, Jason B, MANDAL, Mili, SOMANCHI, Srinivas Sai, FLYNN, Peter, FARRELL, Thomas James, LIM, John Kin Chuan, CHO, Sungyoo, KIM, Yusun, HWANG, Yu Kyeong

Volltext bestellen

TREATMENT OF CANCER WITH NK CELLS AND MULTISPECIFIC ENGAGERS von LITTEN, Jason B, GUERRETTAZ, Lisa, SOMANCHI, Srinivas Sai, FLYNN, Peter, KOCH, Joachim, FARRELL, Thomas James, RAYMON, Heather Karen, PAHL, Jens

Volltext bestellen